PRODUCT LITERATURE

Comparison of efficacy and outcome of intravenous immunoglobulin therapy versus plasmapheresisin patients with Gullian Barre syndrome

---

Acute inflammatory demyelinating polyneuropathy (AIDP) often described as Guillain-Barre syndrome (GBS) is an ascending neuropathy involving demyelination of peripheral nerves. Very few studies on GBS have been conducted in Indian scenario in recent years. Taking into account this background, we undertook this study to have better outlook to the spectrum of disease and outcome. The objective was to study the patient’s clinical profile, outcome of the disease and response to plasmapheresis(PP) versus intravenous immunoglobulin(IVIG) therapyin a case of GBS

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

TEXTBOOK

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Privigen
Gullian Barre syndrome
intravenous immunoglobulin

Specific Detail Info

Int JAdv Med. 2016Aug;3(3):488-494

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment